Cellular thiol-containing proteins

Cellular thiol-containing proteins represent a broad functional class of molecules that utilize the reactive sulfhydryl groups of cysteine residues to sense and respond to the cellular redox environment (Go & Jones, 2013, Free Radic Biol Med). These proteins, which include thioredoxins, glutaredoxins, and the Nrf2-regulator Keap1, act as molecular switches that translate oxidative signals into biological responses such as antioxidant defense or the initiation of apoptosis (Circu & Aw, 2010, Free Radic Biol Med). In many diseases, including cancer and neurodegeneration, the redox state of these thiols is dysregulated, leading to aberrant signaling and cell survival. Therapeutic intervention often involves electrophilic small molecules, such as dimethyl fumarate or bardoxolone methyl, which covalently modify specific cysteine residues to activate protective pathways or induce targeted cell death (Zhang et al., 2013, Nat Rev Drug Discov). Because this term encompasses a wide variety of proteins across multiple pathways rather than a single discrete entity, it is characterized as a collective mechanism of action or a biological pathway rather than a specific therapeutic target.

Other names

Redox-sensitive proteinsThiol-redox proteomeCysteine-containing proteinsSulfhydryl-containing proteins

Covalent modification of reactive cysteine residues (S-alkylation, S-oxidation, or S-nitrosylation) to modulate protein function, typically resulting in the activation of the Nrf2-mediated antioxidant response or the induction of apoptosis via mitochondrial pathways (Jacob et al., 2011, Chem Res Toxicol).